Preoperative Opioid Use and its Association with Postoperative Complications [0.03%]
术前使用阿片类药物及其与术后并发症的关系
Jack D Sudduth,Jessica L Marquez,Catherine H Bautista et al.
Jack D Sudduth et al.
Background: The negative impact of opioid use in the U.S. has led providers to seek alternative methods for pain control. More specifically, preoperative opioid usage has been demonstrated to adversely affect patients and...
Sexual HIV transmission risk behaviors associated with stimulant drug injection among people who non-medically use gabapentin and opioids [0.03%]
与非医学使用加巴喷丁和阿片类药物的人群注射刺激性药物相关的HIV性传播风险行为
Mance E Buttram,Steven P Kurtz
Mance E Buttram
Background: Recent research shows that co-use of stimulants and opioids appears to be increasing and injection of opioids and stimulants carries risk for HIV transmission. This study examined stimulant injection and sexua...
Intersecting Paths: Substance Use Disorder Recovery and Post-Traumatic Growth [0.03%]
交织之路：物质使用障碍康复与创伤后成长
Ducel Jean-Berluche
Ducel Jean-Berluche
This review provides an in-depth analysis of the intersection between substance use disorder (SUD) recovery and post-traumatic growth (PTG). It highlights the transformative journey toward a renewed self and purpose, including personal deve...
Associations between cannabis risk perceptions and Delta-8 THC use among young adults [0.03%]
大麻风险知觉与年轻人大麻二酚使用之间的关联研究
C R LoParco,S T Walters,Z Zhou et al.
C R LoParco et al.
Background: Delta-8 THC is a federally unregulated, implicitly legal, psychoactive substance from the cannabis plant. Delta-8 THC popularity and related consequences have been rising in the U.S. ...
A latent class analysis of alcohol-related problems among adults who drank in the past year [0.03%]
过去一年中饮酒成年人的酒精相关问题的潜在类别分析
Jessica Frankeberger,Robert W S Coulter,Christina Mair
Jessica Frankeberger
Background: Research on alcohol-related problems often examines individual problem types in isolation or uses scales that provide a single cumulative severity score for alcohol-related harms. This study aims to assess the...
Influence of polysubstance use on the health-related quality of life among people who inject drugs undergoing opioid agonist treatment following treatment for hepatitis c virus [0.03%]
多药滥用对接受丙型肝炎治疗后进行阿片类药物激动剂治疗的注射吸毒者健康相关生活质量的影响
Mirinda Ann Gormley,Wanfang Zhang,Stella Self et al.
Mirinda Ann Gormley et al.
Background: Treating hepatitis C virus (HCV) in people who inject drugs (PWID) has been associated with increased health-related quality of life (HRQOL). Polysubstance use (PSU) is common among PWID, but no studies have i...
Development of the Alcohol and Cannabis Simultaneous Use Scale (ACSUS) in College Students [0.03%]
大学生中酒精和大麻同时使用的评估量表（ACSUS）的发展
Haley Kolp,Sarah Horvath,Paula J Fite et al.
Haley Kolp et al.
Background: Despite the prevalence and negative outcomes associated with simultaneous alcohol and cannabis use (i.e., marijuana [SAM] use; i.e., so that the effects of both alcohol and cannabis overlap) among college stud...
Alcohol Use and Life Stressors During the COVID-19 Pandemic: A Longitudinal Study of Young Adults [0.03%]
新冠肺炎疫情期间年轻人的压力和饮酒行为纵向研究
Junhan Cho,Steve Sussman,Afton Kechter et al.
Junhan Cho et al.
Objective: To estimate the extent to which drinking to cope with the COVID-19 pandemic and experiencing pandemic-related life stressors are associated with alcohol use escalation among young adults. ...
Adherence to buprenorphine-XR through hybrid telehealth contingency management procedures: a case series [0.03%]
一种通过混合型远程医疗连续性管理程序坚持布迫酚 XR 治疗的案例系列研究
Jay A Gorman,Alexandria Lindvig-Springborn,Jonathan Lee et al.
Jay A Gorman et al.
Background and objectives: Contingency management (CM) for substance use disorders (SUD) is effective in strengthening recovery behaviors, however can be quite burdensome. When health facilities experience staff shortages...
Open Label Pilot of Lorcaserin (a serotonin 2C-receptor agonist) for Cannabis Use Disorder [0.03%]
氯卡色林（五羟色胺2C受体激动剂）治疗大麻使用障碍的开放性试点研究
Christina A Brezing,Mohammad Sibai,C Jean Choi et al.
Christina A Brezing et al.
Background and objective: Cannabis Use Disorder (CUD) has no FDA approved treatment. Serotonin-2c (5HT2c) agonists have preclinical and human laboratory evidence for potential efficacy for CUD. We assessed the tolerabilit...